Try our mobile app
#reports #DLTR
[Dollar Tree](https://eninvs.com/all.php?name=DLTR) (Store chain owner) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=DLTR&q=2024 q3&id=832117)
(2024-12-04, Before Market Open):
- Revenue +3.5% YoY (vs +0.7% in previous quarter and historical rate +6.3%)
- EBITDA +14.1% YoY (vs -8.2% in previous quarter and historical rate -19.5%)
- EBITDA margin 7.8% increased compared to 7.1% same period last year
- Net Debt decreased by $145 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.5 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 888.7x compared to historical level (75th percentile) of 16.8x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +4.9% vs S&P500 +0.3%
------------------------------------------------
#reports #BOX
[Box](https://eninvs.com/all.php?name=BOX) (Cloud management platform provider ) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=BOX&q=2024 q3&id=832150)
(2024-12-03, After Market Close):
- Revenue +5.3% YoY (vs +3.4% in previous quarter and historical rate +8.7%)
- EBITDA +32.4% YoY (vs -10.6% in previous quarter and historical rate +57.5%)
- EBITDA margin 17.8% increased compared to 14.1% same period last year
- Net Debt increased by $292 mln over the past reporting period (6.4% of market cap)
- FCF (LTM) -$0.3 bln (negative), 6.7% of market cap
- EV/EBITDA multiple is 40.1x compared to historical level (75th percentile) of 68.4x
- EV/Sales multiple is 6x
At the opening of the session the share price went down -1.9% vs S&P500 +0.3%
------------------------------------------------
#reports #VREX
[Varex Imaging](https://eninvs.com/all.php?name=VREX) (Components for X-ray detectors manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VREX&q=2024 q3&id=831352)
(2024-11-19, After Market Close):
- Revenue -9.3% YoY (vs -9.9% in previous quarter and historical rate +0.1%)
- EBITDA -37.1% YoY (vs -44.1% in previous quarter and historical rate -13.1%)
- EBITDA margin 10.7% decreased compared to 15.4% same period last year
- Net Debt decreased by $10 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0 bln (positive), 7.4% of market cap
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 1.1x
The company showed EPS -$1.22 per share. At the opening of the session the share price went up +4.6% vs S&P500 +0.1%
------------------------------------------------
#reports #SNEX
[StoneX Group](https://eninvs.com/all.php?name=SNEX) (Financial service provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SNEX&q=2024 q3&id=831348)
(2024-11-19, After Market Close):
- Revenue +87.2% YoY (vs +79.9% in previous quarter and historical rate +85.4%)
- Net Income +51% YoY (vs -11.4% in previous quarter and historical rate +48.9%)
- Net Income margin 0.2% has not changed compared to 0.3% same period last year
- P/E multiple is 12.1x compared to historical level (75th percentile) of 10x
- P/S multiple is 0x
- Price to book: 2x
At the opening of the session the share price went up +3.7% vs S&P500 +0.1%
------------------------------------------------
#reports #BRBR
[BellRing Brands](https://eninvs.com/all.php?name=BRBR) (Packaged Foods) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=BRBR&q=2024 q3&id=831039)
(2024-11-18, After Market Close):
- Revenue +17.5% YoY (vs +15.5% in previous quarter and historical rate +17.1%)
- EBITDA +44.2% YoY (vs +43.9% in previous quarter and historical rate +43.2%)
- EBITDA margin 20.0% increased compared to 16.3% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 28.7x compared to historical level (75th percentile) of 28.1x
- EV/Sales multiple is 5.3x
The company showed EPS +$0.55 per share. At the opening of the session the share price went down -8.0% vs S&P500 -0.4%
------------------------------------------------
#reports #ACM
[AECOM](https://eninvs.com/all.php?name=ACM) ( Infrastructure-related products provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=ACM&q=2024 q3&id=831029)
(2024-11-18, After Market Close):
- Revenue +7% YoY (vs +13.3% in previous quarter and historical rate +6.7%)
- EBITDA +124.8% YoY (vs +28000.0% in previous quarter and historical rate +29.2%)
- EBITDA margin 6.8% increased compared to 3.3% same period last year
- Net Debt increased by $3.2 bln over the past reporting period (22.2% of market cap)
- FCF (LTM) -$2.8 bln (negative), 18.9% of market cap
- EV/EBITDA multiple is 16.2x compared to historical level (75th percentile) of 28.1x
- EV/Sales multiple is 1x
The company showed EPS +$1.28 per share. At the opening of the session the share price went down -2.2% vs S&P500 -0.4%
------------------------------------------------
#reports #FUTU
@ china , @ saas
[Futu](https://eninvs.com/all.php?name=FUTU) (Capital Markets) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=FUTU&q=2024 q3&id=831011)
(2024-11-19, Before Market Open):
- Revenue +30.8% YoY (vs +26.5% in previous quarter and historical rate +24.0%)
- Net Income +22.3% YoY (vs +8.4% in previous quarter and historical rate +23.2%)
- Net Income margin 38.5% decreased compared to 41.1% same period last year
- P/E multiple is 22.4x compared to historical level (75th percentile) of 19x
- P/S multiple is 8.6x
- Price to book: 3.7x
At the opening of the session the share price went down -1.4% vs S&P500 -0.4%
------------------------------------------------
#reports #WB
@ china
[Weibo](https://eninvs.com/all.php?name=WB) (Social media platform) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=WB&q=2024 q3&id=831024)
(2024-11-19, Before Market Open):
- Revenue +5% YoY (vs -0.5% in previous quarter and historical rate -5.4%)
- EBITDA +4.7% YoY (vs +9.2% in previous quarter and historical rate -17.1%)
- EBITDA margin 33.4% has not changed compared to 33.5% same period last year
- Net Debt increased by $94 mln over the past reporting period (4.4% of market cap)
- EV/EBITDA multiple is 5.7x compared to historical level (75th percentile) of 8.6x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +2.5% vs S&P500 -0.4%
------------------------------------------------
#reports #CLRO
[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=CLRO&q=2024 q3&id=830617)
(2024-11-15, After Market Close):
- Revenue -40% YoY (vs -60.0% in previous quarter and historical rate -22.7%)
- EBITDA margin -66.7% decreased compared to -20.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (16.4% of market cap)
- FCF (LTM) -$0 bln (negative), 122.7% of market cap
- EV/Sales multiple is 0.8x
------------------------------------------------
#reports #AKYA
[Akoya Biosciences, Inc.](https://eninvs.com/all.php?name=AKYA) (Medical Instruments and Supplies) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=AKYA&q=2024 q3&id=830671)
(2024-11-14, After Market Close):
- Revenue -24% YoY (vs -4.2% in previous quarter and historical rate +18.3%)
- EBITDA margin -31.6% increased compared to -36.0% same period last year
- Net Debt increased by $10 mln over the past reporting period (8.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 44.4% of market cap
- EV/Sales multiple is 2x
At the opening of the session the share price went down -33.2% vs S&P500 -0.6%
------------------------------------------------
#reports #BEEM
@ renewable-energy
[Beam Global](https://eninvs.com/all.php?name=BEEM) (Solar) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=BEEM&q=2024 q3&id=830615)
(2024-11-14, Before Market Open):
- Revenue -31.3% YoY (vs -16.7% in previous quarter and historical rate +113.6%)
- EBITDA margin 18.2% increased compared to -18.8% same period last year
- Net Debt increased by $3 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) -$0 bln (negative), 16.0% of market cap
- EV/Sales multiple is 1x
At the opening of the session the share price went down -0.5% vs S&P500 -0.1%
------------------------------------------------
#reports #SBH
[Sally Beauty](https://eninvs.com/all.php?name=SBH) (Professional cosmetics supplier ) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SBH&q=2024 q3&id=830531)
(2024-11-14, Before Market Open):
- Revenue +1.5% YoY (vs +1.2% in previous quarter and historical rate -1.3%)
- EBITDA +6.5% YoY (vs -11.5% in previous quarter and historical rate -3.3%)
- EBITDA margin 8.8% increased compared to 8.4% same period last year
- Net Debt increased by $549 mln over the past reporting period (38.9% of market cap)
- FCF (LTM) -$0.5 bln (negative), 36.9% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 7.9x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +3.4% vs S&P500 -0.1%
------------------------------------------------
#reports #HI
[Hillenbrand](https://eninvs.com/all.php?name=HI) (Diversified industrial company) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=HI&q=2024 q3&id=830571)
(2024-11-13, After Market Close):
- Revenue +317.2% YoY (vs +9.8% in previous quarter and historical rate +30.1%)
- EBITDA margin -4.1% decreased compared to 0.1% same period last year
- Net Debt increased by $1.9 bln over the past reporting period (77.3% of market cap)
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +11.4% vs S&P500 -0.1%
------------------------------------------------
#reports #ELSE
[Electro-Sensors](https://eninvs.com/all.php?name=ELSE) (Scientific and Technical Instruments) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=ELSE&q=2024 q3&id=830565)
(2024-11-13, After Market Close):
- Revenue +250% YoY (vs 0.0% in previous quarter and historical rate +18.1%)
- EV/EBITDA multiple is 4.2x compared to historical level (75th percentile) of 7x
- EV/Sales multiple is 0.3x
------------------------------------------------
#reports #DGII
[Digi International](https://eninvs.com/all.php?name=DGII) (Communication Equipment) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=DGII&q=2024 q3&id=830562)
(2024-11-13, After Market Close):
- Revenue -6.3% YoY (vs -6.3% in previous quarter and historical rate +12.2%)
- EBITDA +8.3% YoY (vs +27.8% in previous quarter)
- EBITDA margin 12.4% increased compared to 10.7% same period last year
- Net Debt increased by $111 mln over the past reporting period (9.6% of market cap)
- EV/EBITDA multiple is 17.8x compared to historical level (75th percentile) of 29x
- EV/Sales multiple is 3x
At the opening of the session the share price went up +2.2% vs S&P500 -0.1%
------------------------------------------------
#reports #NTES
@ china
[NetEase](https://eninvs.com/all.php?name=NTES) (IT services and products provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=NTES&q=2024 q3&id=830524)
(2024-11-14, Before Market Open):
- Revenue -0.1% YoY (vs +5.9% in previous quarter and historical rate +5.1%)
- EBITDA -2.8% YoY (vs +13.2% in previous quarter and historical rate +19.1%)
- EBITDA margin 29.3% decreased compared to 30.1% same period last year
- Net Debt decreased by $1 bln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$2.5 bln (positive), 4.5% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 15.8x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +6.2% vs S&P500 -0.1%
------------------------------------------------
#reports #XGN
[Exagen](https://eninvs.com/all.php?name=XGN) (Diagnostics and Research) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=XGN&q=2024 q3&id=829778)
(2024-11-12, Before Market Open):
- Revenue 0% YoY (vs +7.1% in previous quarter and historical rate +7.2%)
- EBITDA margin -30.8% has not changed compared to -30.8% same period last year
- Net Debt increased by $2 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$0 bln (negative), 10.5% of market cap
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -2.4% vs S&P500 +0.1%
------------------------------------------------
#reports #TH
[Target Hospitality](https://eninvs.com/all.php?name=TH) (Oil and Gas Equipment and Services) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TH&q=2024 q3&id=829765)
(2024-11-12, Before Market Open):
- Revenue -34.9% YoY (vs -29.9% in previous quarter and historical rate +28.7%)
- EBITDA -62.8% YoY (vs -53.6% in previous quarter and historical rate +61.6%)
- EBITDA margin 33.7% decreased compared to 58.9% same period last year
- Net Debt increased by $156 mln over the past reporting period (15.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 7.0% of market cap
- EV/EBITDA multiple is 6.8x compared to historical level (75th percentile) of 7.8x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +3.4% vs S&P500 +0.1%
------------------------------------------------
#reports #SHO
[Sunstone Hotel Investors](https://eninvs.com/all.php?name=SHO) (REIT — Hotel and Motel) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SHO&q=2024 q3&id=829719)
(2024-11-12, Before Market Open):
- Revenue -8.9% YoY (vs -8.7% in previous quarter and historical rate +51.3%)
- EBITDA -20% YoY (vs -14.8% in previous quarter and historical rate +67.4%)
- EBITDA margin 21.2% decreased compared to 24.2% same period last year
- Net Debt increased by $993 mln over the past reporting period (46.9% of market cap)
- FCF (LTM) +$0.3 bln (positive), 14.8% of market cap
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 3.4x
At the opening of the session the share price went down -3.9% vs S&P500 +0.1%
------------------------------------------------
#reports #SHLS
[Shoals Technologies Group, Inc.](https://eninvs.com/all.php?name=SHLS) (Solar) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SHLS&q=2024 q3&id=829718)
(2024-11-12, Before Market Open):
- Revenue -23.9% YoY (vs -16.8% in previous quarter and historical rate +32.5%)
- EBITDA margin 7.8% increased compared to -6.0% same period last year
- Net Debt increased by $128 mln over the past reporting period (15.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.2% of market cap
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 60.1x
- EV/Sales multiple is 2.6x
At the opening of the session the share price went down -3.1% vs S&P500 +0.1%
------------------------------------------------
#reports #SDGR
[Schrodinger/United States](https://eninvs.com/all.php?name=SDGR) (Software developer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SDGR&q=2024 q3&id=829714)
(2024-11-12, Before Market Open):
- Revenue -18.6% YoY (vs -68.6% in previous quarter and historical rate +8.9%)
- EBITDA margin -11.4% increased compared to -127.9% same period last year
- Net Debt decreased by $16 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 6.2% of market cap
- EV/Sales multiple is 8.4x
At the opening of the session the share price went up +17.7% vs S&P500 +0.1%
------------------------------------------------
#reports #RMBL
[RumbleON](https://eninvs.com/all.php?name=RMBL) (Auto and Truck Dealerships) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RMBL&q=2024 q3&id=829711)
(2024-11-12, Before Market Open):
- Revenue -12.7% YoY (vs -12.0% in previous quarter and historical rate +46.8%)
- EBITDA +14.3% YoY (vs +216.7% in previous quarter and historical rate +58.8%)
- EBITDA margin 2.7% increased compared to 2.1% same period last year
- Net Debt decreased by $44 mln over the past reporting period (25.2% of market cap)
- FCF (LTM) -$0.2 bln (negative), 103.9% of market cap
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -3.5% vs S&P500 +0.1%
------------------------------------------------
#reports #RGEN
[Repligen](https://eninvs.com/all.php?name=RGEN) (Highly innovative biotechnological technologies developer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RGEN&q=2024 q3&id=829710)
(2024-11-12, Before Market Open):
- Revenue +9.9% YoY (vs -3.1% in previous quarter and historical rate +5.4%)
- EBITDA -92.9% YoY (vs -64.3% in previous quarter and historical rate -23.2%)
- EBITDA margin 0.6% decreased compared to 9.9% same period last year
- EV/EBITDA multiple is 314.2x compared to historical level (75th percentile) of 97.6x
- EV/Sales multiple is 12.2x
At the opening of the session the share price went up +5.7% vs S&P500 +0.1%
------------------------------------------------
#reports #OPTN
[OptiNose](https://eninvs.com/all.php?name=OPTN) (Drug Manufacturers — Specialty and Generic) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=OPTN&q=2024 q3&id=829700)
(2024-11-12, Before Market Open):
- Revenue -60.8% YoY (vs +5.3% in previous quarter and historical rate +13.2%)
- EBITDA margin -100.0% decreased compared to -39.2% same period last year
- Net Debt decreased by $5 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) +$0 bln (positive), 31.5% of market cap
- EV/Sales multiple is 2x
At the opening of the session the share price went down -10.2% vs S&P500 +0.1%
------------------------------------------------
#reports #NWN
[Northwest Natural Company](https://eninvs.com/all.php?name=NWN) (Utilities — Regulated Gas) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=NWN&q=2024 q3&id=829698)
(2024-11-12, Before Market Open):
- Revenue -2.8% YoY (vs -10.9% in previous quarter and historical rate +12.3%)
- EBITDA +123.1% YoY (vs +8.7% in previous quarter and historical rate +16.0%)
- EBITDA margin 21.2% increased compared to 9.2% same period last year
- Net Debt increased by $129 mln over the past reporting period (10.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 15.8% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 11.5x
- EV/Sales multiple is 2.8x
At the opening of the session the share price went down -0.2% vs S&P500 +0.1%
------------------------------------------------
#reports #NVRO
[Nevro](https://eninvs.com/all.php?name=NVRO) (Medical equipment manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=NVRO&q=2024 q3&id=830000)
(2024-11-11, After Market Close):
- Revenue -6.7% YoY (vs -4.6% in previous quarter and historical rate +2.3%)
- EBITDA margin -11.3% increased compared to -22.1% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 53.4% of market cap
- EV/Sales multiple is 0.4x
At the opening of the session the share price went up +28.6% vs S&P500 +0.1%
------------------------------------------------
#reports #MASS
[908 Devices Inc.](https://eninvs.com/all.php?name=MASS) (Medical Devices) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=MASS&q=2024 q3&id=829687)
(2024-11-12, Before Market Open):
- Revenue +21.4% YoY (vs +16.7% in previous quarter and historical rate +22.0%)
- EBITDA margin -176.5% decreased compared to -64.3% same period last year
- Net Debt increased by $6 mln over the past reporting period (5.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 61.3% of market cap
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -13.8% vs S&P500 +0.1%
------------------------------------------------
#reports #LYV
[Live Nation Entertainment](https://eninvs.com/all.php?name=LYV) (Entertainment services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=LYV&q=2024 q3&id=829984)
(2024-11-11, After Market Close):
- Revenue -6.1% YoY (vs +7.0% in previous quarter and historical rate +81.5%)
- EBITDA +24.3% YoY (vs +14.9% in previous quarter and historical rate +85.9%)
- EBITDA margin 12.4% increased compared to 9.4% same period last year
- Net Debt increased by $1.1 bln over the past reporting period (3.8% of market cap)
- FCF (LTM) -$0.9 bln (negative), 3.0% of market cap
- EV/EBITDA multiple is 19.3x compared to historical level (75th percentile) of 18.7x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went up +4.9% vs S&P500 +0.1%
------------------------------------------------
#reports #JRVR
[James River](https://eninvs.com/all.php?name=JRVR) (Insurance — Specialty) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=JRVR&q=2024 q3&id=829977)
(2024-11-11, After Market Close):
- Revenue -18% YoY (vs -21.0% in previous quarter and historical rate +2.7%)
- Net Income -290% YoY (vs -41.7% in previous quarter and historical rate +50.8%)
- Net Income margin -19.9% decreased compared to 8.6% same period last year
- P/E multiple is 9.4x compared to historical level (75th percentile) of 19.5x
- P/S multiple is 0.2x
- Price to book: 0.3x
At the opening of the session the share price went down -7.3% vs S&P500 +0.1%
------------------------------------------------
#reports #FTCI
[FTC Solar, Inc.](https://eninvs.com/all.php?name=FTCI) (Solar) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=FTCI&q=2024 q3&id=829668)
(2024-11-12, Before Market Open):
- Revenue -67.7% YoY (vs -65.6% in previous quarter and historical rate -18.2%)
- EBITDA margin -150.0% decreased compared to -51.6% same period last year
- Net Debt increased by $3 mln over the past reporting period (6.2% of market cap)
- FCF (LTM) -$0 bln (negative), 47.5% of market cap
- EV/Sales multiple is 0.7x
At the opening of the session the share price went down -6.0% vs S&P500 +0.1%
------------------------------------------------
#reports #FA
[First Advantage Corporation](https://eninvs.com/all.php?name=FA) (Specialty Business Services) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=FA&q=2024 q3&id=829662)
(2024-11-12, Before Market Open):
- Revenue -0.5% YoY (vs 0.0% in previous quarter and historical rate +3.5%)
- Net Income -181.8% YoY (vs -80.0% in previous quarter and historical rate -58.0%)
- Net Income margin -4.5% decreased compared to 5.5% same period last year
- P/E multiple is 535.5x compared to historical level (75th percentile) of 60.5x
- P/S multiple is 3.5x
- Price to book: 2.9x
At the opening of the session the share price went up +12.0% vs S&P500 +0.1%
------------------------------------------------
#reports #EAF
[GrafTech International](https://eninvs.com/all.php?name=EAF) ( Carbon based products manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=EAF&q=2024 q3&id=829656)
(2024-11-12, Before Market Open):
- Revenue -17.6% YoY (vs -26.3% in previous quarter and historical rate -21.3%)
- EBITDA margin -6.1% decreased compared to -0.6% same period last year
- Net Debt decreased by $13 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0 bln (negative), 5.2% of market cap
- EV/Sales multiple is 2.3x
At the opening of the session the share price went up +10.6% vs S&P500 +0.1%
------------------------------------------------
#reports #CBAT
[CBAK Energy Technology](https://eninvs.com/all.php?name=CBAT) (Electrical Equipment and Parts) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=CBAT&q=2024 q3&id=829642)
(2024-11-12, Before Market Open):
- Revenue -22.4% YoY (vs -25.0% in previous quarter and historical rate +53.4%)
- EBITDA -85.7% YoY (vs +800.0% in previous quarter)
- EBITDA margin 2.2% decreased compared to 12.1% same period last year
- Net Debt increased by $28 mln over the past reporting period (31.9% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 5.7x compared to historical level (75th percentile) of 63.5x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +3.4% vs S&P500 +0.1%
------------------------------------------------
#reports #ASRT
[Assertio](https://eninvs.com/all.php?name=ASRT) (Drug Manufacturers — Specialty and Generic) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=ASRT&q=2024 q3&id=829812)
(2024-11-11, After Market Close):
- Revenue -19.4% YoY (vs -24.4% in previous quarter and historical rate +9.1%)
- EBITDA margin 13.8% increased compared to -605.6% same period last year
- EV/EBITDA multiple is 0.9x compared to historical level (75th percentile) of 4.3x
- EV/Sales multiple is -0.1x
At the opening of the session the share price went up +1.1% vs S&P500 +0.1%
------------------------------------------------
#reports #AP
[Ampco-Pittsburgh Corporation](https://eninvs.com/all.php?name=AP) (Metal Fabrication) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=AP&q=2024 q3&id=829631)
(2024-11-12, Before Market Open):
- Revenue -5.9% YoY (vs +3.7% in previous quarter and historical rate +7.2%)
- EBITDA -9.3% YoY (vs +25.0% in previous quarter and historical rate +36.2%)
- EBITDA margin 81.3% decreased compared to 84.3% same period last year
- Net Debt decreased by $143 mln over the past reporting period (380.7% of market cap)
- FCF (LTM) -$0 bln (negative), 16.0% of market cap
- EV/EBITDA multiple is 3.2x compared to historical level (75th percentile) of 17.3x
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -1.1% vs S&P500 +0.1%
------------------------------------------------
#reports #PLUG
@ renewable-energy
[Plug Power](https://eninvs.com/all.php?name=PLUG) (Handling equipment manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PLUG&q=2024 q3&id=829705)
(2024-11-12, Before Market Open):
- Revenue -12.6% YoY (vs -45.0% in previous quarter and historical rate +21.8%)
- EBITDA margin -121.8% increased compared to -135.7% same period last year
- Net Debt decreased by $50 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/Sales multiple is 3.2x
At the opening of the session the share price went down -2.5% vs S&P500 +0.1%
------------------------------------------------
#reports #OUT
@ REITs
[Outfront Media (REIT)](https://eninvs.com/all.php?name=OUT) (REIT — Specialty) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=OUT&q=2024 q3&id=829702)
(2024-11-12, Before Market Open):
- Revenue -0.7% YoY (vs +1.7% in previous quarter and historical rate +12.5%)
- EBITDA +84.6% YoY (vs +24700.0% in previous quarter and historical rate +37.3%)
- EBITDA margin 31.9% increased compared to 17.1% same period last year
- Net Debt increased by $9 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.3 bln (positive), 11.8% of market cap
- EV/EBITDA multiple is 12.9x compared to historical level (75th percentile) of 26x
- EV/Sales multiple is 3.9x
At the opening of the session the share price went down -1.5% vs S&P500 +0.1%
------------------------------------------------
#reports #ZS
@ cybersecurity , @ saas
[Zscaler](https://eninvs.com/all.php?name=ZS) (Internet security platform) reported for [2024 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175068)
(2024-09-03, After Market Close):
- Revenue +30.3% YoY (vs +32.0% in previous quarter and historical rate +48.4%)
- EBITDA >1000% YoY (vs +4700.0% in previous quarter and historical rate +66.7%)
- EBITDA margin 4.7% increased compared to 0.4% same period last year
- Net Debt decreased by $167 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 1042.9x compared to historical level (75th percentile) of 9343.3x
- EV/Sales multiple is 14x
The company showed EPS -$0.1 per share. At the opening of the session the share price went down -17.8% vs S&P500 -0.4%
------------------------------------------------
#reports #XPER
[Xperi](https://eninvs.com/all.php?name=XPER) (Semiconductor Equipment and Materials) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=XPER&q=2024 q3&id=828630)
(2024-11-06, After Market Close):
- Revenue +2.3% YoY (vs -5.5% in previous quarter and historical rate -17.8%)
- EBITDA margin -12.0% increased compared to -20.8% same period last year
- Net Debt increased by $63 mln over the past reporting period (17.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 24.7% of market cap
- EV/Sales multiple is 0.8x
At the opening of the session the share price went down -5.2% vs S&P500 +0.2%
------------------------------------------------
#reports #XHR
[Xenia Hotels & Resorts](https://eninvs.com/all.php?name=XHR) (REIT — Hotel and Motel) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=XHR&q=2024 q3&id=828628)
(2024-11-06, After Market Close):
- Revenue +2.2% YoY (vs +0.7% in previous quarter and historical rate +40.0%)
- EBITDA -4.9% YoY (vs -8.8% in previous quarter and historical rate +39.1%)
- EBITDA margin 16.5% decreased compared to 17.7% same period last year
- Net Debt increased by $1.3 bln over the past reporting period (74.2% of market cap)
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went down -4.6% vs S&P500 +0.2%
------------------------------------------------
#reports #WMB
[Williams](https://eninvs.com/all.php?name=WMB) (Energy company) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=WMB&q=2024 q3&id=828621)
(2024-11-06, After Market Close):
- Revenue +4.5% YoY (vs +4.1% in previous quarter and historical rate +5.4%)
- EBITDA -6.2% YoY (vs +7.5% in previous quarter and historical rate +14.6%)
- EBITDA margin 52.8% decreased compared to 58.8% same period last year
- Net Debt increased by $913 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$3.5 bln (negative), 5.1% of market cap
- EV/EBITDA multiple is 17.4x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 9.5x
At the opening of the session the share price went down -1.4% vs S&P500 +0.2%
------------------------------------------------
#reports #VNDA
[Vanda Pharmaceuticals](https://eninvs.com/all.php?name=VNDA) (Small molecule drugs developer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VNDA&q=2024 q3&id=828610)
(2024-11-06, After Market Close):
- Revenue +23.1% YoY (vs +8.7% in previous quarter and historical rate -9.2%)
- EBITDA margin -22.9% decreased compared to -15.4% same period last year
- Net Debt increased by $11 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 36.7% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 11.3x
- EV/Sales multiple is -0.4x
At the opening of the session the share price went down -1.8% vs S&P500 +0.2%
------------------------------------------------
#reports #VECO
[Veeco Instruments](https://eninvs.com/all.php?name=VECO) (Semiconductor Equipment and Materials) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VECO&q=2024 q3&id=828575)
(2024-11-06, After Market Close):
- Revenue +4.5% YoY (vs +8.6% in previous quarter and historical rate +7.8%)
- EBITDA +6.5% YoY (vs +15.0% in previous quarter and historical rate +12.3%)
- EBITDA margin 17.8% increased compared to 17.5% same period last year
- Net Debt decreased by $16 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 14.3x compared to historical level (75th percentile) of 19.1x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went up +1.5% vs S&P500 +0.2%
------------------------------------------------
#reports #VCYT
[Veracyte](https://eninvs.com/all.php?name=VCYT) (Medical services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VCYT&q=2024 q3&id=828573)
(2024-11-06, After Market Close):
- Revenue +28.9% YoY (vs +26.7% in previous quarter and historical rate +34.4%)
- EBITDA margin 15.5% increased compared to -26.7% same period last year
- Net Debt decreased by $39 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.3% of market cap
- EV/Sales multiple is 6x
At the opening of the session the share price went up +8.5% vs S&P500 +0.2%
------------------------------------------------
#reports #VAC
[Marriott Vacations Worldwide Corporation](https://eninvs.com/all.php?name=VAC) (Vacation services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VAC&q=2024 q3&id=828572)
(2024-11-06, After Market Close):
- Revenue +10% YoY (vs -3.2% in previous quarter and historical rate +12.4%)
- EBITDA +12.3% YoY (vs -5.2% in previous quarter and historical rate +80.8%)
- EBITDA margin 63.1% increased compared to 61.8% same period last year
- Net Debt increased by $454 mln over the past reporting period (11.1% of market cap)
- EV/EBITDA multiple is 1.5x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +4.7% vs S&P500 +0.2%
------------------------------------------------
#reports #XRAY
[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=XRAY&q=2024 q3&id=828139)
(2024-11-07, Before Market Open):
- Revenue +0.4% YoY (vs -4.3% in previous quarter and historical rate -2.7%)
- EBITDA margin -45.1% decreased compared to -21.2% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 4.9% of market cap
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -19.9% vs S&P500 +0.2%
------------------------------------------------
#reports #XPEL
[XPEL](https://eninvs.com/all.php?name=XPEL) (Automotive surface protection products manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=XPEL&q=2024 q3&id=828138)
(2024-11-07, Before Market Open):
- Revenue +9.7% YoY (vs +7.8% in previous quarter and historical rate +21.5%)
- EBITDA +5.3% YoY (vs +5.0% in previous quarter and historical rate +18.8%)
- EBITDA margin 17.7% decreased compared to 18.4% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 34.8x
- EV/Sales multiple is 2.8x
At the opening of the session the share price went down -10.2% vs S&P500 +0.2%
------------------------------------------------
#reports #XMTR
[Xometry, Inc.](https://eninvs.com/all.php?name=XMTR) (Specialty Industrial Machinery) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=XMTR&q=2024 q3&id=824343)
(2024-11-05, Before Market Open):
- Revenue +19.3% YoY (vs +19.8% in previous quarter and historical rate +35.9%)
- EBITDA margin -5.6% increased compared to -9.2% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.1% of market cap
- EV/Sales multiple is 3x
At the opening of the session the share price went up +4.5% vs S&P500 +0.1%
------------------------------------------------
#reports #WYNN
[Wynn Resorts](https://eninvs.com/all.php?name=WYNN) (Hotel and casino chain owner) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=WYNN&q=2024 q3&id=825890)
(2024-11-04, After Market Close):
- Revenue +1.3% YoY (vs +8.6% in previous quarter and historical rate +33.2%)
- EBITDA +23.4% YoY (vs +6.2% in previous quarter and historical rate +101.1%)
- EBITDA margin 17.1% increased compared to 14.1% same period last year
- EV/EBITDA multiple is 5.3x compared to historical level (75th percentile) of 37x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -4.3% vs S&P500 +0.1%
------------------------------------------------
#reports #WRBY
[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=WRBY&q=2024 q3&id=828132)
(2024-11-07, Before Market Open):
- Revenue +12.9% YoY (vs +13.3% in previous quarter and historical rate +12.5%)
- EBITDA margin 1.6% increased compared to -5.9% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/Sales multiple is 2.9x
At the opening of the session the share price went up +0.3% vs S&P500 +0.2%
------------------------------------------------
#reports #WEYS
[Weyco Group](https://eninvs.com/all.php?name=WEYS) (Footwear and Accessories) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=WEYS&q=2024 q3&id=827853)
(2024-11-05, After Market Close):
- Revenue -11.9% YoY (vs -4.5% in previous quarter and historical rate +12.5%)
- EBITDA -15.4% YoY (vs 0.0% in previous quarter and historical rate +22.5%)
- EBITDA margin 14.9% decreased compared to 15.5% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 20.4% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 6.7x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +0.8% vs S&P500 +1.6%
------------------------------------------------
#reports #VTOL
[Bristow Group](https://eninvs.com/all.php?name=VTOL) (Oil and Gas Equipment and Services) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VTOL&q=2024 q3&id=827816)
(2024-11-05, After Market Close):
- Revenue +8% YoY (vs +12.9% in previous quarter and historical rate +5.2%)
- EBITDA +8.5% YoY (vs +158.3% in previous quarter and historical rate +62.7%)
- EBITDA margin 14.0% has not changed compared to 13.9% same period last year
- Net Debt increased by $225 mln over the past reporting period (20.8% of market cap)
- FCF (LTM) -$0.3 bln (negative), 23.6% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 11.1x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +8.1% vs S&P500 +1.6%
------------------------------------------------
#reports #VRTX
[Vertex Pharmaceuticals](https://eninvs.com/all.php?name=VRTX) (Pharmaceutical developer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VRTX&q=2024 q3&id=825822)
(2024-11-04, After Market Close):
- Revenue +11.6% YoY (vs +6.1% in previous quarter and historical rate +14.5%)
- EBITDA +7.3% YoY (vs -455.9% in previous quarter and historical rate +4.9%)
- EBITDA margin 41.4% decreased compared to 43.0% same period last year
- Net Debt increased by $40 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$6.3 bln (negative), 4.9% of market cap
- EV/Sales multiple is 11.7x
At the opening of the session the share price went up +2.2% vs S&P500 +0.1%
------------------------------------------------
#reports #VOYA
[Voya Financial](https://eninvs.com/all.php?name=VOYA) (Insurance company) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VOYA&q=2024 q3&id=825821)
(2024-11-04, After Market Close):
- Revenue +7.3% YoY (vs +8.7% in previous quarter and historical rate +18.6%)
- Net Income -60.2% YoY (vs 0.0% in previous quarter and historical rate +14.2%)
- Net Income margin 5.0% decreased compared to 13.5% same period last year
- P/E multiple is 14x compared to historical level (75th percentile) of 15.4x
- P/S multiple is 1.3x
- Price to book: 2.6x
------------------------------------------------
#reports #VCEL
[Vericel](https://eninvs.com/all.php?name=VCEL) (Medical services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=VCEL&q=2024 q3&id=828124)
(2024-11-07, Before Market Open):
- Revenue +26.1% YoY (vs +15.2% in previous quarter and historical rate +14.0%)
- EBITDA margin -1.7% increased compared to -8.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 397.4x compared to historical level (75th percentile) of 1796x
- EV/Sales multiple is 10.5x
At the opening of the session the share price went up +2.5% vs S&P500 +0.2%
------------------------------------------------
#reports #UFCS
[United Fire](https://eninvs.com/all.php?name=UFCS) (Insurance services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=UFCS&q=2024 q3&id=827760)
(2024-11-05, After Market Close):
- Revenue +17.9% YoY (vs +12.7% in previous quarter and historical rate +3.9%)
- Net Income +233.3% YoY (vs -400.0% in previous quarter and historical rate +46.7%)
- Net Income margin 6.2% increased compared to 2.2% same period last year
- P/E multiple is 11.7x compared to historical level (75th percentile) of 27.6x
- P/S multiple is 0.5x
- Price to book: 0.8x
At the opening of the session the share price went up +10.0% vs S&P500 +1.6%
------------------------------------------------
#reports #TRS
[TriMas](https://eninvs.com/all.php?name=TRS) (Engergy services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TRS&q=2024 q3&id=823508)
(2024-11-04, Before Market Open):
- Revenue -2.6% YoY (vs +3.4% in previous quarter and historical rate +2.9%)
- EBITDA -45.5% YoY (vs -12.5% in previous quarter and historical rate -14.2%)
- EBITDA margin 7.9% decreased compared to 14.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.2% of market cap
- EV/EBITDA multiple is 17.7x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went down -2.6% vs S&P500 -0.1%
------------------------------------------------
#reports #TNDM
[Tandem Diabetes Care](https://eninvs.com/all.php?name=TNDM) (Medical equipment manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TNDM&q=2024 q3&id=828557)
(2024-11-06, After Market Close):
- Revenue +31.2% YoY (vs +13.3% in previous quarter and historical rate +9.8%)
- EBITDA margin -9.4% increased compared to -15.1% same period last year
- Net Debt decreased by $22 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.9% of market cap
- EV/Sales multiple is 2.5x
At the opening of the session the share price went down -4.8% vs S&P500 +0.2%
------------------------------------------------
#reports #TMCI
[Treace Medical Concepts, Inc.](https://eninvs.com/all.php?name=TMCI) (Medical Devices) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TMCI&q=2024 q3&id=827736)
(2024-11-05, After Market Close):
- Revenue +9.8% YoY (vs +4.8% in previous quarter and historical rate +33.6%)
- EBITDA margin -28.9% increased compared to -39.0% same period last year
- Net Debt increased by $13 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0 bln (negative), 6.2% of market cap
- EV/Sales multiple is 2.1x
At the opening of the session the share price went up +25.2% vs S&P500 +1.6%
------------------------------------------------
#reports #TKR
[The Timken Company](https://eninvs.com/all.php?name=TKR) (Power transmission products manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TKR&q=2024 q3&id=824335)
(2024-11-05, Before Market Open):
- Revenue -1.4% YoY (vs -7.1% in previous quarter and historical rate +4.8%)
- EBITDA 0% YoY (vs -12.3% in previous quarter and historical rate +9.5%)
- EBITDA margin 17.9% increased compared to 17.7% same period last year
- Net Debt increased by $121 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 9x compared to historical level (75th percentile) of 9.7x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went down -6.4% vs S&P500 +0.1%
------------------------------------------------
#reports #THR
[Thermon Group](https://eninvs.com/all.php?name=THR) (Specialty Industrial Machinery) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=THR&q=2024 q3&id=828112)
(2024-11-07, Before Market Open):
- Revenue -7.3% YoY (vs +7.5% in previous quarter and historical rate +18.1%)
- EBITDA -19.2% YoY (vs -5.0% in previous quarter and historical rate +42.1%)
- EBITDA margin 18.3% decreased compared to 21.0% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.8% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went down -12.3% vs S&P500 +0.2%
------------------------------------------------
#reports #TCMD
[Tactile Systems Technology](https://eninvs.com/all.php?name=TCMD) (Medical device manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TCMD&q=2024 q3&id=825666)
(2024-11-04, After Market Close):
- Revenue +4.3% YoY (vs +7.4% in previous quarter and historical rate +11.9%)
- EBITDA -10% YoY (vs +100.0% in previous quarter)
- EBITDA margin 12.3% decreased compared to 14.3% same period last year
- Net Debt decreased by $10 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 7.7% of market cap
- EV/EBITDA multiple is 11.3x compared to historical level (75th percentile) of 76x
- EV/Sales multiple is 1.2x
At the opening of the session the share price went down -8.9%
------------------------------------------------
#reports #TBI
[TrueBlue](https://eninvs.com/all.php?name=TBI) (Staffing and Employment Services) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TBI&q=2024 q3&id=825665)
(2024-11-04, After Market Close):
- Revenue -19.2% YoY (vs -16.8% in previous quarter and historical rate -5.9%)
- EBITDA -66.7% YoY (vs -6100.0% in previous quarter and historical rate -30.0%)
- EBITDA margin 0.3% decreased compared to 0.6% same period last year
- Net Debt increased by $12 mln over the past reporting period (4.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 32.2% of market cap
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +5.1% vs S&P500 +0.1%
------------------------------------------------
#reports #SUPN
[Supernus Pharmaceuticals](https://eninvs.com/all.php?name=SUPN) (Pharmaceutical manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SUPN&q=2024 q3&id=825657)
(2024-11-04, After Market Close):
- Revenue +14.3% YoY (vs +23.5% in previous quarter and historical rate +5.8%)
- EBITDA +100% YoY (vs +2400.0% in previous quarter and historical rate +20.1%)
- EBITDA margin 37.5% increased compared to 21.4% same period last year
- Net Debt decreased by $57 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 7.5% of market cap
- EV/EBITDA multiple is 11.2x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 2.5x
At the opening of the session the share price went up +13.5% vs S&P500 +0.1%
------------------------------------------------
#reports #SUP
[Superior Industries International](https://eninvs.com/all.php?name=SUP) (Auto Parts) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SUP&q=2024 q3&id=828104)
(2024-11-07, Before Market Open):
- Revenue -0.3% YoY (vs -14.5% in previous quarter and historical rate +5.2%)
- EBITDA margin 8.1% increased compared to -14.9% same period last year
- Net Debt increased by $255 mln over the past reporting period (340.0% of market cap)
- EV/EBITDA multiple is 3.9x compared to historical level (75th percentile) of 4x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went down -9.4% vs S&P500 +0.2%
------------------------------------------------
#reports #STRA
[Strategic Education](https://eninvs.com/all.php?name=STRA) (Educational service provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=STRA&q=2024 q3&id=828103)
(2024-11-07, Before Market Open):
- Revenue +7% YoY (vs +8.3% in previous quarter and historical rate +2.7%)
- EBITDA +17.5% YoY (vs +65.6% in previous quarter and historical rate +21.3%)
- EBITDA margin 15.4% increased compared to 14.0% same period last year
- Net Debt decreased by $24 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.9% of market cap
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 15.8x
- EV/Sales multiple is 1.8x
At the opening of the session the share price went up +0.3% vs S&P500 +0.2%
------------------------------------------------
#reports #SLNG
[Stabilis Solutions](https://eninvs.com/all.php?name=SLNG) (Oil and Gas Integrated) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SLNG&q=2024 q3&id=828534)
(2024-11-06, After Market Close):
- Revenue +20% YoY (vs +46.2% in previous quarter and historical rate +22.4%)
- EBITDA 0% YoY (vs -100.0% in previous quarter and historical rate +34.7%)
- EBITDA margin 11.1% decreased compared to 13.3% same period last year
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 16.2x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +3.3% vs S&P500 +0.2%
------------------------------------------------
#reports #SHOO
[Steven Madden](https://eninvs.com/all.php?name=SHOO) (Women`s shoes manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SHOO&q=2024 q3&id=828098)
(2024-11-07, Before Market Open):
- Revenue +13% YoY (vs +17.8% in previous quarter and historical rate +13.8%)
- EBITDA -8% YoY (vs +8.3% in previous quarter and historical rate +14.4%)
- EBITDA margin 12.8% decreased compared to 15.7% same period last year
- Net Debt increased by $48 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went up +3.9% vs S&P500 +0.2%
------------------------------------------------
#reports #SEE
[Sealed Air](https://eninvs.com/all.php?name=SEE) (Packaging manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SEE&q=2024 q3&id=828095)
(2024-11-07, Before Market Open):
- Revenue -2.7% YoY (vs -2.6% in previous quarter and historical rate +0.6%)
- EBITDA +13.7% YoY (vs -4.9% in previous quarter and historical rate -0.3%)
- EBITDA margin 17.8% increased compared to 15.3% same period last year
- Net Debt decreased by $82 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.4 bln (positive), 6.8% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 10.4x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went up +4.0% vs S&P500 +0.2%
------------------------------------------------
#reports #SAFT
[Safety Insurance](https://eninvs.com/all.php?name=SAFT) (Insurance — Property and Casualty) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SAFT&q=2024 q3&id=827560)
(2024-11-04, After Market Close):
- Revenue +28.8% YoY (vs +17.9% in previous quarter and historical rate +8.0%)
- Net Income >1000% YoY (vs 0.0% in previous quarter and historical rate -7.4%)
- Net Income margin 8.8% increased compared to 0.9% same period last year
- P/E multiple is 16.7x compared to historical level (75th percentile) of 35.2x
- P/S multiple is 1.2x
- Price to book: 1.6x
At the opening of the session the share price went down -0.3% vs S&P500 +0.1%
------------------------------------------------
#reports #RYTM
[Rhythm Pharmaceuticals](https://eninvs.com/all.php?name=RYTM) (Molecular drug manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RYTM&q=2024 q3&id=827559)
(2024-11-05, After Market Close):
- Revenue +43.5% YoY (vs +52.6% in previous quarter and historical rate +166.6%)
- EBITDA margin -133.3% increased compared to -191.3% same period last year
- Net Debt increased by $5 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.5 bln (negative), 13.0% of market cap
- EV/Sales multiple is 36.7x
At the opening of the session the share price went up +6.7% vs S&P500 +1.6%
------------------------------------------------
#reports #RXRX
[Recursion Pharmaceuticals, Inc.](https://eninvs.com/all.php?name=RXRX) (Biotechnology) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RXRX&q=2024 q3&id=828525)
(2024-11-06, After Market Close):
- Revenue +136.4% YoY (vs +27.3% in previous quarter and historical rate +86.8%)
- EBITDA margin -350.0% increased compared to -836.4% same period last year
- Net Debt increased by $435 mln over the past reporting period (28.1% of market cap)
- FCF (LTM) +$0 bln (positive), 3.1% of market cap
- EV/Sales multiple is 24.6x
At the opening of the session the share price went down -0.7% vs S&P500 +0.2%
------------------------------------------------
#reports #RVLV
[Revolve Group](https://eninvs.com/all.php?name=RVLV) (E-commerce fashion company) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RVLV&q=2024 q3&id=827555)
(2024-11-05, After Market Close):
- Revenue +9.7% YoY (vs +2.9% in previous quarter and historical rate +14.3%)
- EBITDA +700% YoY (vs +100.0% in previous quarter and historical rate +1.6%)
- EBITDA margin 5.7% increased compared to 0.8% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 43.3x compared to historical level (75th percentile) of 40.4x
- EV/Sales multiple is 1.9x
At the opening of the session the share price went up +20.7% vs S&P500 +1.6%
------------------------------------------------
#reports #RLJ
[RLJ Lodging Trust](https://eninvs.com/all.php?name=RLJ) (REIT — Hotel and Motel) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RLJ&q=2024 q3&id=828521)
(2024-11-06, After Market Close):
- Revenue +3.6% YoY (vs +3.4% in previous quarter and historical rate +38.0%)
- EBITDA +7.6% YoY (vs -3.8% in previous quarter and historical rate +89.1%)
- EBITDA margin 24.6% increased compared to 23.7% same period last year
- Net Debt increased by $2.4 bln over the past reporting period (151.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 10.0% of market cap
- EV/EBITDA multiple is 10.7x compared to historical level (75th percentile) of 70.9x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went up +6.6% vs S&P500 +0.2%
------------------------------------------------
#reports #RL
[Ralph Lauren](https://eninvs.com/all.php?name=RL) (Clothing and accessories manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RL&q=2024 q3&id=828090)
(2024-11-07, Before Market Open):
- Revenue +5.7% YoY (vs +1.1% in previous quarter and historical rate +6.5%)
- EBITDA +5.4% YoY (vs +16.9% in previous quarter and historical rate +24.8%)
- EBITDA margin 13.6% has not changed compared to 13.7% same period last year
- Net Debt increased by $55 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.6 bln (positive), 4.3% of market cap
- EV/EBITDA multiple is 15.2x compared to historical level (75th percentile) of 12.4x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went up +10.5% vs S&P500 +0.2%
------------------------------------------------
#reports #RHP
[Ryman Hospitality Properties](https://eninvs.com/all.php?name=RHP) (REIT — Hotel and Motel) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RHP&q=2024 q3&id=825558)
(2024-11-04, After Market Close):
- Revenue +4% YoY (vs +21.4% in previous quarter and historical rate +67.0%)
- EBITDA +3.1% YoY (vs +33.5% in previous quarter and historical rate +98.5%)
- EBITDA margin 30.0% decreased compared to 30.2% same period last year
- Net Debt increased by $3.3 bln over the past reporting period (49.3% of market cap)
- EV/EBITDA multiple is 13.7x compared to historical level (75th percentile) of 23.4x
- EV/Sales multiple is 4.3x
At the opening of the session the share price went down -0.5% vs S&P500 +0.1%
------------------------------------------------
#reports #RGNX
[REGENXBIO](https://eninvs.com/all.php?name=RGNX) (Developer of viral gene therapy) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RGNX&q=2024 q3&id=828520)
(2024-11-06, After Market Close):
- Revenue -17.2% YoY (vs +10.0% in previous quarter and historical rate +5.2%)
- EBITDA margin -229.2% decreased compared to -200.0% same period last year
- Net Debt increased by $34 mln over the past reporting period (6.0% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/Sales multiple is 4.7x
At the opening of the session the share price went up +8.2% vs S&P500 +0.2%
------------------------------------------------
#reports #RARE
[Ultragenyx Pharmaceutical](https://eninvs.com/all.php?name=RARE) (Medicines developer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=RARE&q=2024 q3&id=827473)
(2024-11-05, After Market Close):
- Revenue +41.8% YoY (vs +36.1% in previous quarter and historical rate +14.4%)
- EBITDA margin -74.1% increased compared to -118.4% same period last year
- Net Debt increased by $49 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.4 bln (positive), 9.9% of market cap
- EV/Sales multiple is 5.2x
At the opening of the session the share price went up +0.7% vs S&P500 +1.6%
------------------------------------------------
#reports #QTWO
[Q2](https://eninvs.com/all.php?name=QTWO) (Online banking services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=QTWO&q=2024 q3&id=828511)
(2024-11-06, After Market Close):
- Revenue +12.9% YoY (vs +11.6% in previous quarter and historical rate +12.4%)
- EBITDA margin 6.3% increased compared to 0.6% same period last year
- Net Debt decreased by $35 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 156.2x compared to historical level (75th percentile) of 845.7x
- EV/Sales multiple is 9.2x
At the opening of the session the share price went up +4.4% vs S&P500 +0.2%
------------------------------------------------
#reports #PZZA
[Papa Johns International](https://eninvs.com/all.php?name=PZZA) (Owner of restaurants) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PZZA&q=2024 q3&id=828085)
(2024-11-07, Before Market Open):
- Revenue -3.1% YoY (vs -1.4% in previous quarter and historical rate +17.5%)
- EBITDA +72.9% YoY (vs -9.8% in previous quarter and historical rate +29.9%)
- EBITDA margin 16.4% increased compared to 9.2% same period last year
- Net Debt increased by $5 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 7.1x compared to historical level (75th percentile) of 20.3x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +1.5% vs S&P500 +0.2%
------------------------------------------------
#reports #PSTL
[Postal Realty Trust](https://eninvs.com/all.php?name=PSTL) (REIT — Office) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PSTL&q=2024 q3&id=825468)
(2024-11-04, After Market Close):
- Revenue +25% YoY (vs +20.0% in previous quarter and historical rate +24.2%)
- EBITDA +22.2% YoY (vs +25.0% in previous quarter and historical rate +48.7%)
- EBITDA margin 55.0% decreased compared to 56.3% same period last year
- Net Debt increased by $305 mln over the past reporting period (114.3% of market cap)
- EV/EBITDA multiple is 15x compared to historical level (75th percentile) of 22.7x
- EV/Sales multiple is 7.9x
At the opening of the session the share price went up +1.4% vs S&P500 +0.1%
------------------------------------------------
#reports #PSNL
[Personalis](https://eninvs.com/all.php?name=PSNL) (Diagnostics and Research) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PSNL&q=2024 q3&id=828506)
(2024-11-06, After Market Close):
- Revenue +44.4% YoY (vs +35.3% in previous quarter and historical rate +4.3%)
- EBITDA margin -53.8% increased compared to -166.7% same period last year
- Net Debt decreased by $50 mln over the past reporting period (22.1% of market cap)
- FCF (LTM) -$0 bln (negative), 14.6% of market cap
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -14.0% vs S&P500 +0.2%
------------------------------------------------
#reports #PRIM
[Primoris Services](https://eninvs.com/all.php?name=PRIM) (Engineering and Construction) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PRIM&q=2024 q3&id=825457)
(2024-11-04, After Market Close):
- Revenue +7.8% YoY (vs +10.7% in previous quarter and historical rate +22.0%)
- EBITDA -9.6% YoY (vs +14.3% in previous quarter and historical rate +7.4%)
- EBITDA margin 7.4% decreased compared to 8.8% same period last year
- Net Debt decreased by $156 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 8.8x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +0.4% vs S&P500 +0.1%
------------------------------------------------
#reports #PRAA
[PRA](https://eninvs.com/all.php?name=PRAA) (Financial services provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PRAA&q=2024 q3&id=825440)
(2024-11-04, After Market Close):
- Revenue +30.1% YoY (vs +35.9% in previous quarter and historical rate +0.9%)
- Net Income margin 10.3% increased compared to -3.7% same period last year
- P/E multiple is 15.9x compared to historical level (75th percentile) of 30.9x
- P/S multiple is 0.9x
- Price to book: 0.8x
At the opening of the session the share price went up +8.0% vs S&P500 +0.1%
------------------------------------------------
#reports #POWI
[Power Integrations](https://eninvs.com/all.php?name=POWI) (Analog integrated circuits manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=POWI&q=2024 q3&id=828499)
(2024-11-06, After Market Close):
- Revenue -7.9% YoY (vs -13.8% in previous quarter and historical rate -14.6%)
- EBITDA -25.9% YoY (vs -50.0% in previous quarter and historical rate -26.4%)
- EBITDA margin 17.2% decreased compared to 21.4% same period last year
- Net Debt increased by $290 mln over the past reporting period (7.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 69.8x compared to historical level (75th percentile) of 53.4x
- EV/Sales multiple is 8.5x
At the opening of the session the share price went up +3.2% vs S&P500 +0.2%
------------------------------------------------
#reports #PMTS
[CPI Card Group](https://eninvs.com/all.php?name=PMTS) (Credit Services) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PMTS&q=2024 q3&id=824318)
(2024-11-05, Before Market Open):
- Revenue +17.9% YoY (vs +3.5% in previous quarter and historical rate +10.9%)
- Net Income -75% YoY (vs -14.3% in previous quarter and historical rate +22.6%)
- Net Income margin 0.8% decreased compared to 3.8% same period last year
- P/E multiple is 9.4x compared to historical level (75th percentile) of 9.5x
- P/S multiple is 0.7x
- Price to book: -6.8x
At the opening of the session the share price went up +3.1% vs S&P500 +0.1%
------------------------------------------------
#reports #PKOH
[Park-Ohio](https://eninvs.com/all.php?name=PKOH) (Specialty Industrial Machinery) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PKOH&q=2024 q3&id=828495)
(2024-11-06, After Market Close):
- Revenue -0.2% YoY (vs +1.2% in previous quarter and historical rate +5.4%)
- EBITDA -5.9% YoY (vs +22.2% in previous quarter and historical rate +55.1%)
- EBITDA margin 7.7% decreased compared to 8.1% same period last year
- Net Debt decreased by $23 mln over the past reporting period (5.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 27.6x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went up +3.3% vs S&P500 +0.2%
------------------------------------------------
#reports #PENN
[Penn National Gaming](https://eninvs.com/all.php?name=PENN) (Provider of entertainment services) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PENN&q=2024 q3&id=828038)
(2024-11-07, Before Market Open):
- Revenue +1.2% YoY (vs -0.7% in previous quarter and historical rate +7.0%)
- EBITDA margin 10.7% increased compared to -42.1% same period last year
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 11.8x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +1.5% vs S&P500 +0.2%
------------------------------------------------
#reports #PEG
[Public Service Enterprise](https://eninvs.com/all.php?name=PEG) (Energy provider) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PEG&q=2024 q3&id=823502)
(2024-11-04, Before Market Open):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +9.2%)
- EBITDA +12.2% YoY (vs -19.2% in previous quarter and historical rate +51.7%)
- EBITDA margin 38.1% increased compared to 33.9% same period last year
- EV/EBITDA multiple is 11.1x compared to historical level (75th percentile) of 53.5x
- EV/Sales multiple is 3.7x
At the opening of the session the share price went down -3.6% vs S&P500 -0.1%
------------------------------------------------
#reports #PCRX
[Pacira BioSciences](https://eninvs.com/all.php?name=PCRX) (Medicines manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PCRX&q=2024 q3&id=828491)
(2024-11-06, After Market Close):
- Revenue +3% YoY (vs +5.3% in previous quarter and historical rate +11.2%)
- EBITDA -628% YoY (vs -25.0% in previous quarter and historical rate -5.9%)
- EBITDA margin -78.1% decreased compared to 15.2% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 10.9% of market cap
- EV/Sales multiple is 1.7x
At the opening of the session the share price went down -0.5% vs S&P500 +0.2%
------------------------------------------------
#reports #PBH
[Prestige Consumer Healthcare](https://eninvs.com/all.php?name=PBH) (Medicines manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=PBH&q=2024 q3&id=828036)
(2024-11-07, Before Market Open):
- Revenue -0.7% YoY (vs -4.3% in previous quarter and historical rate +3.0%)
- EBITDA -4.2% YoY (vs -14.0% in previous quarter and historical rate +2.9%)
- EBITDA margin 32.4% decreased compared to 33.6% same period last year
- Net Debt decreased by $59 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 4.4% of market cap
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 464.7x
- EV/Sales multiple is 4.5x
At the opening of the session the share price went up +0.3% vs S&P500 +0.2%
------------------------------------------------
#reports #OSCR
[Oscar Health, Inc.](https://eninvs.com/all.php?name=OSCR) (Healthcare Plans) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=OSCR&q=2024 q3&id=828033)
(2024-11-07, Before Market Open):
- Revenue +68.3% YoY (vs +45.8% in previous quarter and historical rate +81.0%)
- Net Income margin -2.2% increased compared to -4.6% same period last year
- P/E multiple is 114.5x compared to historical level (75th percentile) of 284.3x
- P/S multiple is 0.4x
- Price to book: 2.9x
At the opening of the session the share price went down -8.2% vs S&P500 +0.2%
------------------------------------------------
#reports #OLPX
[Olaplex Holdings, Inc.](https://eninvs.com/all.php?name=OLPX) (Specialty Retail) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=OLPX&q=2024 q3&id=828032)
(2024-11-07, Before Market Open):
- Revenue -4% YoY (vs -4.6% in previous quarter and historical rate -18.4%)
- EBITDA -20.5% YoY (vs -9.5% in previous quarter and historical rate -43.6%)
- EBITDA margin 26.1% decreased compared to 31.5% same period last year
- Net Debt decreased by $32 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.7% of market cap
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went down -10.1% vs S&P500 +0.2%
------------------------------------------------
#reports #OFIX
[Orthofix Medical](https://eninvs.com/all.php?name=OFIX) (Medical equipment manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=OFIX&q=2024 q3&id=828031)
(2024-11-07, Before Market Open):
- Revenue +7.1% YoY (vs +6.4% in previous quarter and historical rate +22.8%)
- EBITDA margin -6.1% decreased compared to -1.6% same period last year
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -0.5% vs S&P500 +0.2%
------------------------------------------------
#reports #OESX
[Orion Energy Systems](https://eninvs.com/all.php?name=OESX) (Electrical Equipment and Parts) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=OESX&q=2024 q3&id=825996)
(2024-11-06, Before Market Open):
- Revenue -9.5% YoY (vs +11.1% in previous quarter and historical rate -11.3%)
- EBITDA margin -15.8% increased compared to -19.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0 bln (negative), 6.3% of market cap
- EV/Sales multiple is 0.4x
At the opening of the session the share price went up +0.9% vs S&P500 +1.6%
------------------------------------------------
#reports #ODP
[Office Depot](https://eninvs.com/all.php?name=ODP) (Specialty Retail) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=ODP&q=2024 q3&id=825995)
(2024-11-06, Before Market Open):
- Revenue -11.4% YoY (vs -10.0% in previous quarter and historical rate -7.6%)
- EBITDA +5.9% YoY (vs -78.7% in previous quarter and historical rate +0.9%)
- EBITDA margin 7.1% increased compared to 5.9% same period last year
- Net Debt increased by $44 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 16.2% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 10.5x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went down -9.9% vs S&P500 +1.6%
------------------------------------------------
#reports #OB
[Outbrain Inc.](https://eninvs.com/all.php?name=OB) (Internet Content and Information) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=OB&q=2024 q3&id=828029)
(2024-11-07, Before Market Open):
- Revenue -2.6% YoY (vs -5.3% in previous quarter and historical rate -2.1%)
- EBITDA -85.7% YoY (vs -300.0% in previous quarter and historical rate -41.1%)
- EBITDA margin 0.4% decreased compared to 3.0% same period last year
- Net Debt increased by $31 mln over the past reporting period (12.5% of market cap)
- FCF (LTM) -$0 bln (negative), 13.7% of market cap
- EV/EBITDA multiple is 107.5x compared to historical level (75th percentile) of 34.7x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +5.0% vs S&P500 +0.2%
------------------------------------------------
#reports #NXST
[Nexstar Media](https://eninvs.com/all.php?name=NXST) (Media company) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=NXST&q=2024 q3&id=828028)
(2024-11-07, Before Market Open):
- Revenue +20.7% YoY (vs +2.3% in previous quarter and historical rate +3.6%)
- EBITDA +67.2% YoY (vs +1.6% in previous quarter and historical rate +3.4%)
- EBITDA margin 38.4% increased compared to 27.7% same period last year
- Net Debt decreased by $6.7 bln over the past reporting period (90.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 7.8x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +3.7% vs S&P500 +0.2%
------------------------------------------------
#reports #NOVT
[Novanta](https://eninvs.com/all.php?name=NOVT) (Scientific and Technical Instruments) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=NOVT&q=2024 q3&id=824311)
(2024-11-05, Before Market Open):
- Revenue +9.9% YoY (vs +3.1% in previous quarter and historical rate +12.7%)
- EBITDA +11.9% YoY (vs -9.1% in previous quarter and historical rate +14.7%)
- EBITDA margin 19.3% increased compared to 18.9% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 43.6x compared to historical level (75th percentile) of 43x
- EV/Sales multiple is 7.5x
At the opening of the session the share price went down -8.3% vs S&P500 +0.1%
------------------------------------------------
#reports #NEO
[NeoGenomics](https://eninvs.com/all.php?name=NEO) (Network of clinical laboratories) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=NEO&q=2024 q3&id=824308)
(2024-11-05, Before Market Open):
- Revenue +10.5% YoY (vs +12.2% in previous quarter and historical rate +10.1%)
- EBITDA margin -1.8% increased compared to -3.9% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/Sales multiple is 3.4x
At the opening of the session the share price went down -4.2% vs S&P500 +0.1%
| Rising Stars Strategy |
No companies |
| US Leaders Strategy |
No companies |
| Covered by screener |
No companies |
| Other companies |
No companies |
